The device is implanted in the chest and can be activated with a remote before to going to bed. The product is expected to hit the market later this year but the price is still to be determined.
Obstructive sleep apnea (OSA) is reported to occur as many as 83% of women and 92% of men. OSA is a condition in which the breathing passage collapses or becomes blocked during sleep. With insufficient oxygen, cellular regeneration is unable to transpire nightly during sleep. Poor cellular regeneration results in an individual being more susceptible to numerous pathologies anywhere in the body. Complications from sleep apnea include heart disease and increased risks of accidents and death. OSA is the disease that dentistry now leads the world in for accepted treatment of the afflicted.1
"This therapy represents a major advance in sleep apnea treatment for some patients," said Meir Kryger, professor at the Yale School of Medicine about the Inspire upper Airway Stimulation therapy. ?There is a significant need for safe, effective and well-tolerated new treatments in the sleep medicine field."